$RDRSF RDARS Inc. to Present at the OTCQB Venture Virtual

New Post Public Reply Private Reply Replies (0) Message Board
louied91
203
$RDRSF RDARS Inc. to Present at the OTCQB Venture Virtual Investor Conference August 3rd

https://www.globenewswire.com/news-release/20...t-3rd.html

TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- RDARS Inc. (“RDARS” or the “Company”) (CSE: RDRS) (OTCQB: RDRSF), based in Toronto, Ontario, Canada, an autonomous robotics and drone technology company developing advanced systems for alarm system augmentation and surveillance, today announced that Charles Zwebner, Chief Executive Officer, will present live at the OTCQB Venture Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on August 3rd , 2023.

DATE: August 3rd
TIME: 12:00 PM ET
LINK: https://bit.ly/3J2h3Of
Available for 1x1 meetings: August 3

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revolutionary AI Improves Immunology and Cancer Research Efficiency

Updated Category News Views 107

Transforming Research with AI Technology BD (Becton, Dickinson and Company) (NYSE: BDX) has recently launched an innovative tool that is set to transform the landscape of immunology and cancer research. The introduction of the BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, is redefining how scientists approach experimental design in these critical...

Continue Reading
Strategic Collaboration of IONETIX and AlfaRim Medical Unveiled

Updated Category News Views 347

Strategic Partnership Between IONETIX and AlfaRim Medical In a significant move within the medical isotope industry, IONETIX Corporation has announced a strategic partnership with AlfaRim Medical B.V. This collaboration sets the stage for accelerating the commercial production of Actinium-225, a crucial isotope used in targeted alpha therapies for various cancers. As...

Continue Reading
Endeavour Silver's Terronera Project Achieves Major Milestones

Updated Category News Views 62

Endeavour Silver's Terronera Project Update: Key Developments Endeavour Silver Corp. (NYSE: EXK; TSX: EDR) has unveiled a significant third-quarter construction progress report for its Terronera Project located in Mexico. The company takes pride in its remarkable strides toward achieving full operational readiness. Progress Overview The Terronera Project has progressed...

Continue Reading
Healthcare Sector Faces Major Cybersecurity Challenges Amid Breaches

Updated Category News Views 224

Significant Rise in Healthcare Data Breaches In the healthcare industry, data breaches hit a dramatic peak, leading to an alarming tally of over 276 million records compromised. This stunning figure represents a staggering 64.1% increase from prior years, illustrating profound vulnerabilities in the protection of sensitive patient information. As such, the harsh reality...

Continue Reading
Tempus AI Investors Prepare for Class Action Opportunity

Updated Category News Views 131

Understanding the Tempus AI Class Action Lawsuit Investors in Tempus AI, Inc. (NASDAQ: TEM) may find themselves in a position to lead a class action lawsuit following substantial financial losses. This legal opportunity arises from significant allegations against the company, which purports to be advancing precision medicine through artificial intelligence. Who Can...

Continue Reading